Zimovetz EA, Bischof M, Joseph A, Mauskopf J. Cost-utility analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the United Kingdom. Poster presented at the 23rd European Congress of Psychiatry; March 28, 2015. Vienna, Austria.